![Mark Etherton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Etherton
Directeur/Bestuurslid bij
ARGENICA THERAPEUTICS LIMITED
Profiel
Mark Etherton is a Non-Executive Director at Argenica Therapeutics Ltd. since 2024.
Formerly, Dr. Etherton was an Associate Medical Director at Biogen, Inc. from 2022 to 2023.
Dr. Etherton earned a doctorate from The University of Texas Southwestern Medical Center.
Actieve functies van Mark Etherton
| Bedrijven | Functie | Begin |
|---|---|---|
| ARGENICA THERAPEUTICS LIMITED | Directeur/Bestuurslid | 17-09-2024 |
Eerdere bekende functies van Mark Etherton
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2023 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Mark Etherton
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
The University of Texas Southwestern Medical Center
 The University of Texas Southwestern Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argenica Therapeutics Ltd.
 Argenica Therapeutics Ltd. BiotechnologyHealth Technology Develops novel neuro protective therapeutics to reduce brain damage | Health Technology |
